Significantly, the percentage of the OCA treatment-related suppression of apoptotic (TUNEL+ and Annexin-5+PI+) splenocytes and the increase in proliferative/active splenocytes were higher in the NASH-OCA group than those in the NASH and Ctrl groups, respectively. This evidence concerns the gene ANXA5 and metabolic dysfunction-associated steatohepatitis.